Literature DB >> 7870428

[Administration of the cervical torsion test by the examination of Doppler's blood flows in vertebral arteries and basilar artery in patients with degenerative cervical spine changes].

J Olszewski1, P Zalewski, W Machała, W Gaszyński.   

Abstract

Using the neck rotation test during examination of Doppler's blood flows in vertebral arteries and basilar artery, the authors examined 60 subjects aged 16-60 years, including 20 healthy ones and 40 with cervical spondylarthrosis. The Transpect-TCD was used. Half the patients with cervical spine changes had also receptive hearing damage of low degree. The study demonstrated that neck rotation affected of patological Doppler's blood flows in one or in both vertebral arteries at 50% patients with cervical spondylarthrosis, but without clinical symptoms, and at 70% patients with cervical spondylarthrosis and clinical symptoms. The neck rotation test can have diagnostic significance by examination of sufficiency in vertebrobasilar system, or qualitative significance to microsurgical treatment.

Entities:  

Mesh:

Year:  1994        PMID: 7870428

Source DB:  PubMed          Journal:  Otolaryngol Pol        ISSN: 0030-6657


  3 in total

1.  Effect of cervical spondylosis on vertebral arterial flow and its association with vertigo.

Authors:  Ilkay Koray Bayrak; Dilek Durmus; Ayse Oytun Bayrak; Baris Diren; Ferhan Canturk; Feryal Canturk
Journal:  Clin Rheumatol       Date:  2008-08-08       Impact factor: 2.980

2.  Vertigo is associated with advanced degenerative changes in patients with cervical spondylosis.

Authors:  Shereen A Machaly; Mohammed K Senna; Ahmed G Sadek
Journal:  Clin Rheumatol       Date:  2011-05-20       Impact factor: 2.980

3.  Lateral medullary infarction with similar features of Brown Sequard syndrome caused by vertebrobasilar dysplasia and Klippel-Feil syndrome: A case report.

Authors:  Jingzhe Han; Duanhua Cao; Guomei Ma; Tingting Wang; Ye Ji; Zhilei Kang
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.